News
the global demand for mRNA vaccines and therapeutics is at an all-time high. Now more than ever, robust process development and manufacturing are essential to ensure patients have access to life ...
5h
Vietnam Investment Review on MSNEverest Medicines to Remove B Marker from Stock Code on May 2 2025Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...
SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a ...
2don MSN
Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...
SK Bioscience announced Wednesday that it has secured a definitive legal victory in its patent invalidation suit against Moderna, successfully challenging the biotech giant’s Korean patent related to ...
Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could prevent mRNA, as well as siRNA and ASO therapeutics, from reaching their full potential ...
The 2 nd Annual mRNA-Based Therapeutics Summit Europe is returning in-person to Berlin this January 24-26. Expect exclusive data from the movers and shakers in mRNA vaccine and therapy ...
Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results